PlainRecalls
FDA Drug Moderate Class II Terminated

Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87

Reported: May 18, 2016 Initiated: April 12, 2016 #D-0852-2016

Product Description

Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87

Reason for Recall

Discoloration: presence of atypical yellow discoloration of the solution .

Details

Recalling Firm
Baxter Healthcare Corp.
Units Affected
11,630 babs
Distribution
Nationwide
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87. Recalled by Baxter Healthcare Corp.. Units affected: 11,630 babs.
Why was this product recalled?
Discoloration: presence of atypical yellow discoloration of the solution .
Which agency issued this recall?
This recall was issued by the FDA Drug on May 18, 2016. Severity: Moderate. Recall number: D-0852-2016.